Filtered By:
Condition: Stroke
Procedure: Angioplasty

This page shows you your search results in order of relevance. This is page number 8.

Order by Relevance | Date

Total 4288 results found since Jan 2013.

O17 Profile of intracranial artery calcifications and effect on endovascular stroke treatment
ConclusionsIntracranial arterial calcifications within the symptomatic vessel are associated with worse angiographic and functional outcomes. Identification of symptomatic-IAC on baseline imaging may predict need of intracranial stenting and determine their optimal endovascular treatment strategy.ReferencesMaurer CJ, et al. Endovascular Thrombectomy of Calcified Emboli in Acute Ischemic Stroke: A Multicenter Study. AJNR. 2020 Mar;41(3):464–468.Johnson S, Mccarthy R, Fahy B, et al. Development of an in vitro Model of Calcified Cerebral Emboli in Acute Ischemic Stroke for Mechanical Thrombectomy Evaluation. J Neurointe...
Source: Journal of NeuroInterventional Surgery - August 29, 2022 Category: Neurosurgery Authors: Rodrigo-Gisbert, M., Requena, M., Rubiera, M., Lozano, P., De Dios Lascuevas, M., Garcia-Tornel, A., Olive-Gadea, M., Boned, S., Muchada, M., Rodriguez-Villatoro, N., Rodriguez-Luna, D., Juega, J., Pagola, J., Pinana, C., Hernandez, D., Molina, C., Tomase Tags: 14th Congress of the European Society of Minimally Invasive Neurological Therapy 2022 Meeting Abstracts Source Type: research

Systemic thrombolysis for stroke in pregnancy
Pregnancy is an exclusion criterion for all clinical trials that validate alteplase in acute stroke, so our knowledge about its use in this condition is relative only to case reports and case series. Herein, we report the successful use of intravenous recombinant tissue-type plasminogen activator (rt-PA) in pregnant women with acute stroke. The patient was a 28-year-old who was 16 weeks pregnant. She presented to our hospital 1 hour after a sudden onset of mothor aphasia, hemiparesis, and hypoesthesia on the right side due to incipient ischemia in the left cerebral hemisphere resulting from ipsilateral middle cerebral arte...
Source: The American Journal of Emergency Medicine - August 6, 2012 Category: Emergency Medicine Authors: Rossana Tassi, Maurizio Acampa, Giovanna Marotta, Samuele Cioni, Francesca Guideri, Simone Rossi, Alfonso Cerase, Giuseppe Martini Tags: Case Reports Source Type: research

The incidence and risk factors of stroke in patients with acute myocardial infarction treated invasively and concomitant impaired renal function.
Abstract BACKGROUND: Impaired : renal function is a marker of poor prognosis in patients with acute myocardial infarction (AMI). The aim of the study was to assess the incidence and independent predictors of stroke in population of patients with AMI treated invasively and concomitant impaired renal function (IRF). METHODS: We analyzed 2,520 consecutive AMI-patients admitted to our Center between 2003 and 2007 and treated with percutaneous coronary intervention. The whole population was divided into patients with IRF, defined as glomerular filtration rate < 60 ml/min/1.73m² or contrast induced nephropathy (IRF-...
Source: Cardiology Journal - May 15, 2013 Category: Cardiology Authors: Podolecki TS, Lenarczyk R, Kowalczyk J, Swiątkowski A, Chodór P, Pruszkowska-Skrzep P, Sędkowska A, Poloński L, Kalarus Z Tags: Cardiol J Source Type: research

Patients with Acute Coronary Syndrome and Stroke Throughout the Acute Healthcare Chain
For patients with acute coronary syndrome (ACS) and stroke, prompt diagnosis and treatment is essential. In most cases of myocardial infarction, blood flow needs to be restored through percutaneous coronary intervention (PCI) or through thrombolytic medications. Treatments are most effective if started as early as possible. For patients with ST-elevated myocardial infarction (STEMI), PCI should be started within 90 min. For ischemic stroke patients, thrombolysis with recombinant tissue plasminogen activator needs to be given within 4.5 h after onset of symptoms. Before a patient reaches a PCI center or stroke unit, he may ...
Source: The Journal of Emergency Medicine - January 23, 2014 Category: Emergency Medicine Authors: R. Egberink, M. Zwerink, H. Droste, P. Brouwers, G. Van Houwelingen, C. Doggen Source Type: research

The American Heart Association - American Stroke Association and Medtronic Collaborate to Reduce Recurrent Strokes
The American Heart Association/American Stroke Association (AHA/ASA) and Medtronic plc (NYSE: MDT), today announced a collaboration to reduce the rate of recurrent strokes in the U.S. The two organizations will work together over several years to educate, raise awareness and support effective management of patients who have strokes, one of the most devastating diseases affecting Americans today. The initiative, announced at the American Stroke Association's annual International Stroke Conference in Nashville, Tennessee, will focus on reducing strokes of unknown cause, called "cryptogenic stroke."
Source: News from Angioplasty.Org - February 19, 2015 Category: Cardiology Source Type: news

Can we make stroke during cardiac surgery a never event?
Stroke has been and continues to be the Achilles heel of cardiac surgery. Periprocedural neurologic events during cardiac surgery remain prevalent, with stroke reported in 2.0% to 4.6% of patients undergoing cardiac surgery and increasing to at least 12.8% in octogenarians.1-3 The fear of stroke or other adverse neurologic outcomes, including so-called pump head, is a deterrent for patients to undergo the otherwise successful, life-saving operations that we perform. The interpretation of the SYNTAX trial “that with coronary artery bypass grafting (CABG) the patient is trading a 3 times higher risk of stroke (2.2% vs 0.6%...
Source: The Journal of Thoracic and Cardiovascular Surgery - February 28, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Michael Mack Tags: Editorial commentary Source Type: research

Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS
Conclusions Individualized treatment of ICAD using tailored devices according to arterial access and lesion morphology was feasible and safe in symptomatic patients caused by hypoperfusion with poor collateral flow.
Source: Journal of NeuroInterventional Surgery - April 13, 2015 Category: Neurosurgery Authors: Miao, Z., Song, L., Liebeskind, D. S., Liu, L., Ma, N., Wang, Y., Mo, D., Gao, F., Zhao, X., Dong, K., Zhang, D., Gao, P. Tags: Ischemic stroke Source Type: research

An Unusual Case of Acquired Alexia without Agraphia Caused by Perioperative Stroke (P4.368)
Conclusions: Though rare, perioperative strokes occur and are often unidentified. Proceduralists and anesthesiologists should not delay emergent neurological assessment for fear of treatment futility. Though many postoperative patients are not candidates for intravenous thrombolysis, endovascular catheter-based interventions can be considered.Disclosure: Dr. Sener has nothing to disclose. Dr. Siegel has nothing to disclose. Dr. Eidelman has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Sener, U., Siegel, J., Eidelman, B. Tags: Cerebrovascular Case Reports Source Type: research

E-020 Between a Rock and a Hard Place: The Use of Self-expanding Stents for the Endovascular Treatment of Acute Ischemic Stroke due to Recalcitrant Emergency Large Vessel Occlusion in the Era of Stent-retrievers: Single-center Experience and Early Results
ConclusionInitial results suggest that acute intracranial stenting may be beneficial in a subset of patients who present with an ELVO and who have failed recanalization by means of mechanical thrombectomy with stent-retrievers and/or thromboaspiration with large bore intracranial catheters.DisclosuresJ. Lozano: None. M. Howk: None. A. Kuhn: None. F. Massari: None. K. de Macedo Rodrigues: None. C. Brooks: None. M. Perras: None. M. Gounis: 1; C; NIH, Medtronic Neurovascular, Microvention/Terumo, Cerevasc LLC, Gentuity, Codman Neurovascular, Phillips Healthcare, Stryker Neurovascular, Tay Sachs Foundation, InNeuroCo Inc. 2; C...
Source: Journal of NeuroInterventional Surgery - July 28, 2016 Category: Neurosurgery Authors: Lozano, J., Howk, M., Kuhn, A., Massari, F., de Macedo Rodrigues, K., Brooks, C., Perras, M., Gounis, M., Rex, D., Wakhloo, A., Puri, A. Tags: Electronic poster abstracts Source Type: research

Incidence and Clinical Significance of Acute Reocclusion after Emergent Angioplasty or Stenting for Underlying Intracranial Stenosis in Patients with Acute Stroke INTERVENTIONAL
CONCLUSIONS: Acute reocclusion of treated arteries was common after emergent intracranial angioplasty with or without stent placement in patients with acute stroke with intracranial atherosclerotic stenosis and was associated with a poor outcome. Suboptimal results of angioplasty appear to be associated with acute reocclusion, irrespective of whether stent placement was performed.
Source: American Journal of Neuroradiology - September 8, 2016 Category: Radiology Authors: Kim, G. E., Yoon, W., Kim, S. K., Kim, B. C., Heo, T. W., Baek, B. H., Lee, Y. Y., Yim, N. Y. Tags: INTERVENTIONAL Source Type: research

Revascularization of tandem occlusions in acute ischemic stroke: review of the literature and illustrative case.
CONCLUSIONS In stroke patients with tandem occlusions, distal to proximal revascularization represents a reasonable treatment approach and may offer the advantage of decreased time to reperfusion, which is associated with better functional outcome. Further studies are warranted to determine the best techniques in endovascular therapy to use in this subset of patients in order to improve clinical outcome. PMID: 28366063 [PubMed - in process]
Source: Neurosurgical Focus - April 1, 2017 Category: Neurosurgery Authors: Mbabuike N, Gassie K, Brown B, Miller DA, Tawk RG Tags: Neurosurg Focus Source Type: research

Current medical and surgical stroke prevention therapies for patients with carotid artery stenosis.
Abstract Carotid artery stenosis (CAS) is a marker of systemic atherosclerosis and patients with CAS are at high risk of vascular events in multiple vascular locations, including ipsilateral ischemic stroke. Both medical and surgical therapies have been demonstrated effective in reducing this risk. The optimal management for patients with asymptomatic carotid artery stenosis remains controversial. In patients with symptomatic CAS ≥70%, CEA has been demonstrated to reduce the risk of stroke. With risk of recurrent stroke being particularly high in the first 2 weeks after first event, CEA or carotid angioplasty wi...
Source: Current Neurovascular Research - January 31, 2019 Category: Neurology Authors: Jusufovic M, Skagen K, Krohg-Sørensen K, Skjelland M Tags: Curr Neurovasc Res Source Type: research

Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor?
We report two cases of patients with AMI complicating ischemic stroke, successfully treated with cangrelor infusion, which was started during PCI and maintained up to 48 h at bridge therapy dosage (0.75 mcg/kg/min). Both patients underwent successful PCI in the acute phase, and neither ischemic nor hemorrhagic complications occurred during in-hospital stay. PMID: 31066332 [PubMed - as supplied by publisher]
Source: Platelets - May 10, 2019 Category: Hematology Tags: Platelets Source Type: research

Therapeutic effect of pre-operative tirofiban on patients with acute ischemic stroke with mechanical thrombectomy within 6-24 hours.
CONCLUSION: The use of tirofiban before MT can shorten the procedure time and improve the recanalization rate of occluded vessels in AIS patients. PMID: 31112428 [PubMed - as supplied by publisher]
Source: Interventional Neuroradiology - May 23, 2019 Category: Radiology Tags: Interv Neuroradiol Source Type: research

Mean Platelet Volume-To-Lymphocyte Ratio Predicts Poor Functional Outcomes Among Ischemic Stroke Patients Treated With Intravenous Thrombolysis
Conclusions: Both the values of MPVLR at admission and 18–24 h after intravenous thrombolysis were independently associated with poor functional outcomes. MPVLR may serve as an activity marker for a poor prognosis in patients with acute ischemic stroke receiving intravenous thrombolysis.
Source: Frontiers in Neurology - December 9, 2019 Category: Neurology Source Type: research